This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4d09
From Proteopedia
| Line 20: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 4d09" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4d09" style="background-color:#fffaf0;"></div> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Phosphodiesterase|Phosphodiesterase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:34, 6 November 2017
PDE2a catalytic domain in complex with a brain penetrant inhibitor
| |||||||||||
Categories: 3',5'-cyclic-nucleotide phosphodiesterase | Andres, J I | Buijnsters, P | DeAngelis, M | Langlois, X | Rombouts, F | Sanderson, W | Trabanco, A | Tresadern, G | VanHoof, G | VanRoosbroeck, Y | Animal | Cyclic nucleotide phosphodiesterase | Disease model | Drug evaluation | Hydrolase | Phosphodiesterase 2 inhibitor | Phosphodiesterase inhibitor | Preclinical | Protein binding | Structure-activity relationship | Type 2 | Type 4
